SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly
period ended March 31, 2003
Commission file number 0-19841
i-STAT Corporation
(Exact name of
Registrant as specified in its charter)
| Delaware | 22-2542664 | ||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||
| 104 Windsor Center Drive, East Windsor, NJ | 08520 | ||
| (Address of Principle Executive Offices) | (Zip Code) | ||
(609) 443-9300
(Registrants
telephone number, including area code)
| Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. |
| Yes ___X____ No_______ |
| Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act) |
| Yes _____ No____X__ |
| The number of shares outstanding of each Issuer's classes of Common Stock as of the latest practicable date. |
| Class | May 1, 2003 |
| Common Stock, $0.15 par value | 20,137,342 |
i-STAT CORPORATION
TABLE OF CONTENTS
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Condensed Statements of Operations for thePART II OTHER INFORMATION
Item 4 - Submission of Matters to a Vote of Security Holders Item 6 - Exhibits and Reports on Form 8-K SIGNATURES CERTIFICATIONS2
| Three Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, |
|||||||||||
| 2003 |
2002 |
||||||||||
| Net revenues: | |||||||||||
| Related party net revenues | $ | 12,971 | $ | 11,556 | |||||||
| Third party net revenues | 2,237 | 2,669 | |||||||||
| Other related party net revenues | 175 | 175 | |||||||||
| Total net revenues | 15,383 | 14,400 | |||||||||
| Cost of net revenues | 11,481 | 12,748 | |||||||||
| Gross margin on total net revenues | 3,902 | 1,652 | |||||||||
| Operating expenses: | |||||||||||
| Research and development | 1,721 | 1,886 | |||||||||
| Sales and marketing | 2,670 | 2,180 | |||||||||
| General and administrative | 1,616 | 1,527 | |||||||||
| Total operating expenses | 6,007 | 5,593 | |||||||||
| Operating loss | (2,105 | ) | (3,941 | ) | |||||||
| Other income, net | 1,542 | 189 | |||||||||
| Net loss | (563 | ) | (3,752 | ) | |||||||
| Accretion of Preferred Stock | (114 | ) | (112 | ) | |||||||
| Dividends on Preferred Stock | (413 | ) | (549 | ) | |||||||
| Net loss available to Common Stockholders | ($ 1,090 | ) | ($ 4,413 | ) | |||||||
| Basic and diluted net loss per share | |||||||||||
| available to Common Stockholders | ($ 0.05 | ) | ($ 0.22 | ) | |||||||
| Shares used in computing basic and diluted net | |||||||||||
| loss per share available to Common Stockholders | 20,117,110 | 19,980,887 | |||||||||
The accompanying notes are an integral part of these consolidated financial statements.
3
| March 31, 2003 |
December 31, 2002 |
|||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 11,612 | $ | 27,059 | ||||
| Martketable securities, current | 11,796 | | ||||||
| Accounts receivable from related party, net | 5,990 | 7,070 | ||||||
| Accounts receivable, net | 1,030 | 393 | ||||||
| Inventories (Note 2) | 13,622 | 14,509 | ||||||
| Prepaid expenses and other current assets | 1,210 | 2,089 | ||||||
| Total current assets | 45,260 | 51,120 | ||||||
| Martketable securities, long-term | 4,595 | | ||||||
| Plant and equipment, net of accumulated depreciation of $39,299 as | ||||||||
| of March 31, 2003 and $36,130 as of December 31, 2002 | 11,900 | 11,858 | ||||||
| Other assets | 978 | 980 | ||||||
| Total assets | $ | 62,733 | $ | 63,958 | ||||
| Liabilities, Redeemable Preferred Stock and Stockholders' Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 1,603 | $ | 2,927 | ||||
| Accrued expenses | 3,879 | 4,860 | ||||||
| Related party liability, current | 10,019 | 10,019 | ||||||
| Deferred revenue, current | 120 | 30 | ||||||
| Total current liabilities | 15,621 | 17,836 | ||||||
| Deferred revenue, non-current | 1,900 | | ||||||
| Related party liability, non-current (Note 11) | 47,000 | 47,000 | ||||||
| Total liabilities | 64,521 | 64,836 | ||||||
| Series D Redeemable Convertible Preferred Stock, liquidation value | ||||||||
| $33,270 in 2003 and $32,617 in 2002 | 28,988 | 28,223 | ||||||
| Stockholders' deficit: | ||||||||
| Preferred Stock, $0.10 par value, shares authorized 7,000,000: | ||||||||
| Series A Junior Participating Preferred Stock, $0.10 par | ||||||||
| value, 1,500,000 shares authorized; none issued | | | ||||||
| Series C Convertible Preferred Stock, 25,000 shares | ||||||||
| authorized; none issued | | | ||||||
| Common Stock, $0.15 par value, 50,000,000 shares authorized; | ||||||||
| 20,157,927 shares issued and 20,117,110 | ||||||||
| shares outstanding as of March 31, 2003 and December 31, 2002 | 3,024 | 3,024 | ||||||
| Treasury Stock, at cost, 40,817 shares | (750 | ) | (750 | ) | ||||
| Additional paid-in capital | 252,006 | 252,771 | ||||||
| Loan to officer, net | (12 | ) | (93 | ) | ||||
| Accumulated deficit | (283,568 | ) | (283,005 | ) | ||||
| Accumulated other comprehensive loss | (1,476 | ) | (1,048 | ) | ||||
| Total stockholders' deficit | (30,776 | ) | (29,101 | ) | ||||
| Total liabilities, redeemable preferred stock and stockholders' deficit | $ | 62,733 | $ | 63,958 | ||||
The accompanying notes are an integral part of these consolidated financial statements.
4
| Three Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, |
|||||||||||
| 2003 |
2002 |
||||||||||
| Cash flows from operating activities: | |||||||||||
| Net loss | ($563 | ) | ($3,752 | ) | |||||||
| Adjustment to reconcile net loss to net cash | |||||||||||
| provided by (used in) operating activities | (133 | ) | 736 | ||||||||
| Change in assets and liabilities | 2,203 | 2,558 | |||||||||
| Net cash provided by (used in) operating activities | 1,507 | (458 | ) | ||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of marketable securities | (16,391 | ) | | ||||||||
| Purchases of equipment | (502 | ) | (858 | ) | |||||||
| Other | (20 | ) | (21 | ) | |||||||
| Net cash used in investing activities | (16,913 | ) | (879 | ) | |||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from stock options exercised | | 77 | |||||||||
| Expenses related to private placement of Series D | |||||||||||
| Redeemable Convertible Preferred Stock | |||||||||||
| and Warrants | | (47 | ) | ||||||||
| Net cash provided by financing activities | | 30 | |||||||||
| Effect of currency exchange rate changes on cash | (41 | ) | (16 | ) | |||||||
| Net decrease in cash and cash equivalents | (15,447 | ) | (1,323 | ) | |||||||
| Cash and cash equivalents at beginning of period | 27,059 | 43,112 | |||||||||
| Cash and cash equivalents at end of period | $ | 11,612 | $ | 41,789 | |||||||
The accompanying notes are an integral part of these consolidated financial statements.
5
(unaudited)
Basis of Presentation
| The information presented as of March 31, 2003, and for the three months ended March 31, 2003 and 2002, is unaudited, but includes all adjustments (consisting of normal recurring accruals except for the inventory adjustment that was recorded in the first quarter of 2002, see Note 2) which the management of i-STAT Corporation (the Company) believes to be necessary for the fair presentation of results for the periods presented. The results for the interim periods are not necessarily indicative of results to be expected for the year. The December 31, 2002 consolidated condensed balance sheet data was derived from the audited financial statements, but does not include all disclosures required by generally accepted accounting principles. These consolidated condensed financial statements should be read in conjunction with the Companys audited financial statements for the year ended December 31, 2002, including the Notes thereto, which were included as part of the Companys Annual Report on Form 10-K, File No. 0-19841. |
Reclassification
| Certain reclassifications have been made to 2002 amounts in order to conform them to the 2003 presentation. |
Marketable Securities
| Marketable securities, current and long-term, consist of fixed-income investments in United States Treasury securities with a maturity of greater than three months from the date of purchase. The Company applies Statement of Financial Accounting Standards (SFAS) No. 115 Accounting for Certain Investments in Debt and Equity Securities to its investments in marketable securities. The Companys marketable securities are classified as held-to-maturity and are recorded at amortized cost. |
| At March 31, 2003, marketable securities consisted of the following: |
| Amortized Cost |
Market Value |
Unrealized Gain | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands of dollars) | |||||||||||
| U.S. Treasury securities - current | $ | 11,796 | $ | 11,799 | $ | 3 | |||||
| U.S. Treasury securities - long-term | 4,595 | 4,600 | 5 | ||||||||
| $ | 16,391 | $ | 16,399 | $ | 8 | ||||||
Basic and Diluted Loss per Share
| Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of Common Shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in the earnings of the Company. The Company has not included potentially dilutive Common Shares in the diluted per-share computation for the periods presented, as the result is antidilutive due to the Companys net loss. |
| Options to purchase 4,042,471 shares of common stock at $2.24 $32.58 per share, which expire on various dates from May 2003 to February 2013, were outstanding at March 31, 2003. In addition, warrants to purchase 1,875,357.5 shares of Common Stock at $8.00 per share were outstanding at March 31, 2003. The options and warrants were not included in the computation of diluted loss per share because the effect would be antidilutive (i.e., decrease the net loss per share) due to the Companys net loss. |
6
Comprehensive Income
| SFAS No. 130, Reporting Comprehensive Income, requires certain items to be included in other comprehensive income. The only component of accumulated other comprehensive income (loss) for the Company is foreign currency translation adjustments resulting from the translation of the financial statements of the Companys Canadian subsidiary. |
| Three Months |
Ended March 31, |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands of dollars) |
2003 |
2002 |
|||||||||
| Net loss | ($563 | ) | ($3,752 | ) | |||||||
| Other comprehensive income (loss): | |||||||||||
| Foreign currency translation | (428) | 16 | |||||||||
| Comprehensive loss | ($ 991 | ) | ($3,736 | ) | |||||||